Abstract
Controversy still surrounds the issue of whether or not HLA matching should be used for recipient selection. There is lingering doubt that HLA ty** can select out such superior grafts from cadaver donors; even though, there is universal agreement that HLA can identify superior sibling — donor transplants (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Salvatierra, O.: Living related transplantation results. In: L.H. Toledo-Pereyra (ed.), Kidney Transplantation,p. 369. Davis, Philadelphia (1988).
Terasaki, P.I., Vredevoe, D.L. and Mickey, M.R.: Seroty** for homotransplantation. X. Survival of 196 grafted kidneys subsequent to ty**. Transplantation 5, 1057 (1967).
Patel, R., Mickey, M.R. and Terasaki, P.I.: Seroty** for homotransplantation. XVI. Analysis of kidney transplants from unrelated donors. New Engl. J. Med. 279, 501 (1958).
Mickey, M.R., Kreisler, M., Albert, E.D. et al.: Analysis of HLA incompatibility in human renal transplants. Tissue Antigens 1, 57 (1971).
Opelz, G. and Terasaki, P.I.: International histocompatibility workshop study on renal transplantation. In: P.T. Terasaki (ed.), Histocompatibility Testing 1980, p. 592. UCLA Tissue Ty** Laboratory, Los Angeles (1980).
Opelz, G.: Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment. Transplantation 40 240 (1985).
Mickey, M.R.: HLA matching effects. In: P.I. Terasaki (ed.), Clinical Transplants 1987, p. 303. UCLA Tissue Ty** Laboratory, Los Angeles (1987).
Cicciarelli, J. and Corcoran, S.: An update on HLA matching, including HLA ‘epitope’ matching: a new approach. In: P.I. Terasaki (ed.), Clinical Transplants 1988, p. 329. UCLA Tissue Ty** Laboratory, Los Angeles (1988).
Sanfilippo, F., Vaughn, W.K., Alexander, J.W., LeFor, W.M., Lucas, B.A. and Pfaff, W.W.: Organ sharing for good HLA-A, B, and DR matching improves cadaver renal graft survival in SEOPF: retrospective and prospective studies considering delayed graft function, race, center effects, cyclosporine, and other factors. In: P.I. Terasaki (ed.), Clinical Transplants 1988, p. 211. UCLA Tissue Ty** Laboratory, Los Angeles (1988).
Persijn, G.G., D’Amaro, J., de Lange, P. et al.: The effect of mismatching and sharing of HLA-A, -B, and -DR antigens on kidney graft survival in Eurotransplant 1982 to 1988. In: P.I. Terasaki (ed.), Clinical Transplants 1988, p. 237. UCLA Tissue Ty** Laboratory, Los Angeles (1988).
Gore, S.M., Gilks, W.R. and Bradley, B.A.: Transplantation Statistics in the UK - and agenda for the next quinquennium. In: P.I. Terasaki (ed), Clinical Transplants 1988,p. 225. UCLA Tissue Ty** Laboratory, Los Angeles (1988).
Najarian, J.S., Migliori, R.J., Simmons, R.L. et al.: Effects of HLA matching in cadaver renal transplants. Transplant. Proc. 20(3), 249 (1988).
Stratta, R.J., Armbrust, M.J., Lorentzen, D.F. et al.: Cadaveric renal transplantation in the cyclosporine and OKT3 eras: the University of Wisconsin-Madison experience. In: P.I. Terasaki (ed.), Clinical Transplants 1987, p. 183. UCLA Tissue Ty** Laboratory, Los Angeles (1987).
Dyer, P.A., Martin, S., Mallick, N.P. et al.: Kidney transplantation in the northwest region of England - experience of 1132 transplants in 21 years. In: P.I. Terasaki, (ed.), Clinical Transplants 1987, p. 201. UCLA Tissue Ty** Laboratory, Los Angeles (1989).
Cicciarelli, J., Mendez, R., Mendez, R. et al.: The long term matching effect from a single large center. Transplant. Proc. (in press).
Cook, D.J.: Long-term survival of kidney allografts. In: P.I. Terasaki, (ed.), Clinical Transplants 1987, p. 277. UCLA Tissue Ty** Laboratory, Los Angeles (1987).
Miller, R.G. Jr, Gong, G. and Munoz, A.: Survival Analysis, p. 51. Wiley, New York (1981).
Takiff, H., Mickey, M.R. and Terasaki, P.I.: Factors important in 10-year kidney transplant survival. In: P.I. Terasaki, (ed.), Clinical Transplants 1986,p. 157. UCLA Tissue Ty** Laboratory, 1986.
Fleiss, J.L.: Statistical Methods for Rates and Proportions, p. 161. Wiley, New York (1973).
Imagawa, D.K. and Cecka J.M.: Renal regrafts. In: P.I. Terasaki (ed.), Clinical Transplants 1988, p. 387. UCLA Tissue Ty** Laboratory, Los Angeles (1988).
Neppert, J., Nunez, G. and Stastny, P.: HLA-A, B, C; -DR; -MT, -MB, and SB antigens on unstimulated human endothelial cells. Tissue Antigens 24 40 (1990).
Porter, K.A.: Histopathology in clinical renal transplantation. Transplant. Proc. 6 79 (1974).
Terasaki, P.I. and Opelz, G.: Fifteen years of HL-A: what is the importance of HL-A compatibility for clinical outcome of renal transplantation? Vox Sang. 34 171 (1978).
Lau, M., Terasaki, P.I., Park, M.S. and Barbetti, A.: Fifteen-year overview of the international cell exchange. In: P.I. Terasaki (ed.), Clinical Transplants 1989,p. 447. UCLA Tissue Ty** Laboratory, Los Angeles (1989).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Gjertson, D.W., Terasaki, P.I. (1991). HLA matching and organ transplantation. In: Abouna, G.M., Kumar, M.S.A., White, A.G. (eds) Organ Transplantation 1990. Developments in Surgery, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3386-9_4
Download citation
DOI: https://doi.org/10.1007/978-94-011-3386-9_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5497-3
Online ISBN: 978-94-011-3386-9
eBook Packages: Springer Book Archive